Literature DB >> 22380998

Gliomatosis peritonei: recurrence, treatment and surveillance.

Pablo Menéndez-Sánchez1, Pedro Villarejo-Campos, David Padilla-Valverde, Cristina Murillo-Lázaro, Jesús Martín-Fernández.   

Abstract

BACKGROUND: Gliomatosis peritonei is the metastatic implantation of mature glial tissue within the peritoneal cavity of patients with ovarian teratomas. There is no clear guidance for how long these patients should be followed up. CLINICAL CASE: We report the follow-up imaging findings of a 33-year-old female with abdominal distension and abdominal pain and who was postoperatively diagnosed with immature ovarian teratoma with gliomatosis peritonei.
CONCLUSIONS: Differentiation of peritoneal implants seems to be important for prognosis. Malignant transformations after several years cannot be excluded. Therefore, new studies will determine if it is necessary to create guidelines for the postsurgical monitoring of these patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22380998

Source DB:  PubMed          Journal:  Cir Cir        ISSN: 0009-7411            Impact factor:   0.361


  4 in total

1.  Gliomatosis Peritonei Arising in Setting of Immature Teratoma of Ovary: A Case Report and Review of Literature.

Authors:  Nisha Marwah; Ashima Batra; Sumiti Gupta; Savita Rani Singhal; Rajeev Sen
Journal:  J Obstet Gynaecol India       Date:  2015-07-17

2.  Gliomatosis peritonei with bilateral ovarian teratomas: A report of two cases.

Authors:  Jiawei Wang; Jingjing Xu; Minming Zhang; Baizhou Li
Journal:  Oncol Lett       Date:  2016-07-15       Impact factor: 2.967

3.  [Recurrence of an immature ovarian teratoma with peritoneal gliomatosis].

Authors:  Houssine Boufettal; Naïma Samouh
Journal:  Pan Afr Med J       Date:  2015-01-21

4.  Presentation of a Patient who Underwent Fertility-Sparing Surgeries for Contralateral Recurrence of Ovarian Immature Teratoma with Gliomatosis Peritonei.

Authors:  Saori Seo; Yoshinari Matsumoto; Miho Tsukioka; Toshiyuki Sumi; Kenichi Wakasa; Osamu Ishiko
Journal:  Jpn Clin Med       Date:  2013-05-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.